
Varex Imaging (VREX) Stock Forecast & Price Target
Varex Imaging (VREX) Analyst Ratings
Bulls say
Varex Imaging is on track for a strong recovery in both its Medical and Industrial segments, with sequential growth in both segments and record-setting performance in its Industrial segment in FY25. The company's strategic initiatives, including ramping production in India and developing new technologies such as photon counting CT detectors, position it for long-term growth and improved margins. With a strong cash position, end-customer stickiness, and attractive recurring revenue base, Varex is a deep-value name with a potential for positive surprises in the future.
Bears say
Varex Imaging is facing strong competition in the medical imaging market, with competitors such as GE Healthcare, Varian, Siemens, Philips, Elekta, Medtronic, Toshiba, and Canon. This competition, combined with the company's heavy reliance on the EMEA region for revenue, makes it vulnerable to economic fluctuations and geopolitical risks. Additionally, Varex Imaging's financial performance has been stagnant in recent years, with declining revenues and profitability, indicating potential underlying issues within the company's operations and strategy. Overall, these factors contribute to a negative outlook for Varex Imaging's stock.
This aggregate rating is based on analysts' research of Varex Imaging and is not a guaranteed prediction by Public.com or investment advice.
Varex Imaging (VREX) Analyst Forecast & Price Prediction
Start investing in Varex Imaging (VREX)
Order type
Buy in
Order amount
Est. shares
0 shares